Detalles de la búsqueda
1.
[A prospective multi-center trial of non-interventional and observational study of lenalidomide in Chinese patients with multiple myeloma].
Zhonghua Nei Ke Za Zhi
; 56(7): 500-506, 2017 Jul 01.
Artículo
en Zh
| MEDLINE | ID: mdl-28693058
2.
[A predictive model based on risk factors for early mortality in patients with newly diagnosed multiple myeloma].
Zhonghua Xue Ye Xue Za Zhi
; 42(8): 666-672, 2021 Aug 14.
Artículo
en Zh
| MEDLINE | ID: mdl-34547873
3.
[Epidemiological analysis of cytogenetic abnormalities in patients with newly-diagnosed multiple myeloma: a multi-center retrospective study].
Zhonghua Xue Ye Xue Za Zhi
; 41(1): 10-15, 2020 Jan 14.
Artículo
en Zh
| MEDLINE | ID: mdl-32023748
4.
[Adverse effects of double-hit combining ISS-â ¢ stage and 1q gain or del (17p) on prognosis of patients with newly diagnosed multiple myeloma].
Zhonghua Xue Ye Xue Za Zhi
; 40(11): 912-917, 2019 Nov 14.
Artículo
en Zh
| MEDLINE | ID: mdl-31856439
5.
[Prognostic analysis of 182 newly diagnosed multiple myeloma patients with high risk cytogenetic abnormalities].
Zhonghua Xue Ye Xue Za Zhi
; 40(8): 644-649, 2019 Aug 14.
Artículo
en Zh
| MEDLINE | ID: mdl-31495130
6.
[The prognostic significance of dynamic monitoring of minimal residual disease (MRD) status in patients with newly-diagnosed multiple myeloma].
Zhonghua Xue Ye Xue Za Zhi
; 40(7): 584-588, 2019 Jul 14.
Artículo
en Zh
| MEDLINE | ID: mdl-32397022
7.
[Effect of 1q21 amplification on bortezomib therapeutic response and prognosis of newly diagnosed multiple myeloma patients].
Zhonghua Xue Ye Xue Za Zhi
; 39(5): 408-413, 2018 May 14.
Artículo
en Zh
| MEDLINE | ID: mdl-29779352
8.
[Metachronous multiple carcinoma of bilateral maxillary sinus and lung: a case report].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
; 57(6): 746-748, 2022 Jun 07.
Artículo
en Zh
| MEDLINE | ID: mdl-35725322
9.
[A retrospective study of the BiRd regimen in the treatment of relapsed/ refractory multiple myeloma].
Zhonghua Xue Ye Xue Za Zhi
; 38(10): 837-841, 2017 Oct 14.
Artículo
en Zh
| MEDLINE | ID: mdl-29166734
10.
Albumin inhibits apolipoprotein AI and AII production in human hepatoblastoma cell line (Hep G2): additive effects of oleate-albumin complex.
Atherosclerosis
; 149(1): 43-9, 2000 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-10704613
11.
[Transdermal delivery of cyclosporin A solubilized in mixed micelles through mice skin].
Yao Xue Xue Bao
; 36(5): 381-5, 2001 May.
Artículo
en Zh
| MEDLINE | ID: mdl-12584864
12.
[Effect of processing contents of saccharides in Danggui].
Zhongguo Zhong Yao Za Zhi
; 25(8): 474-5, 2000 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-12515208
13.
[Advances on immunomodulatory drugs against multiple myeloma].
Zhonghua Xue Ye Xue Za Zhi
; 37(3): 262-4, 2016 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-27033772
14.
Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.
Cell
; 88(3): 417-26, 1997 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-9039268
15.
Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport.
Arterioscler Thromb Vasc Biol
; 17(10): 2020-8, 1997 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-9351367
16.
Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells.
Arterioscler Thromb Vasc Biol
; 19(4): 1051-9, 1999 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-10195935
17.
Estradiol stimulates apolipoprotein A-I- but not A-II-containing particle synthesis and secretion by stimulating mRNA transcription rate in Hep G2 cells.
Arterioscler Thromb Vasc Biol
; 18(6): 999-1006, 1998 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-9633943
18.
Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2).
Arterioscler Thromb Vasc Biol
; 16(8): 1052-62, 1996 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-8696946
19.
Characterization of a monoclonal antibody (HB-22) and development of an ELISA for human apolipoprotein A-I.
Clin Chem
; 41(8 Pt 1): 1150-8, 1995 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-7628090
20.
Uremic serum subfraction inhibits apolipoprotein A-I production by a human hepatoma cell line.
J Am Soc Nephrol
; 5(2): 193-200, 1994 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-7993998